A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome

Clinical trial NCT05843162 · UNKNOWN

Trial details

NCT number: NCT05843162
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Essential Hypertension Metabolic Syndrome

Start date: 2023-06-01
Primary completion: 2023-12-31
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.